Gene Silencing Market, By Product & Service (Products and Services), By Application, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
|
Report ID
AV3884
|
Published Date
June 2025
|
Pages
298
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Gene Silencing Market size was valued at USD 9,940.32 Million in 2024, expanding at a CAGR of 13.64% from 2024 to 2032.
Gene silencing is the biological process of turning off or significantly reducing the expression of specific genes. This can occur naturally through mechanisms such as RNA interference (RNAi), where small RNA molecules bind to messenger RNA (mRNA) and prevent its translation into proteins. Alternatively, gene silencing can be artificially induced using advanced techniques like RNA-based therapies or CRISPR-Cas systems, which target and degrade specific mRNA sequences or directly modify gene function. Gene silencing plays a critical role in regulating gene expression, maintaining cellular homeostasis, and defending against viral infections. Moreover, it holds immense therapeutic potential for treating a variety of genetic disorders and diseases by selectively controlling or inhibiting harmful gene activity.
Gene Silencing Market- Market Dynamics
Increasing Demand for Personalized Medicine
The rising demand for personalized medicine is a key driver in the biotechnology market. Advances in genomics and molecular biology have paved the way for treatments tailored to an individual’s unique genetic makeup, enhancing therapeutic efficacy while minimizing adverse effects. As both patients and healthcare providers increasingly recognize the benefits of customized therapies, personalized medicine is gaining widespread adoption across diverse therapeutic areas such as oncology, neurology, and rare diseases. This growing trend fuels demand for innovative biotechnological solutions and stimulates significant investment in precision diagnostics, genetic testing, and targeted treatments, thereby propelling the overall growth of the market.
In India, the personalized medicine sector is experiencing robust growth. The market was valued at approximately 1,08,000 crore (US$13.2 billion) in 2022 and is projected to reach 1,93,000 crore (US$23.3 billion) by 2032, growing at a compound annual growth rate (CAGR) of 5.89% . This expansion is supported by government initiatives such as the 64,000 crore (US$7.7 billion) project to establish 22 AI Institutes of Precision Medicine, aimed at leveraging artificial intelligence for advanced diagnostics and personalized healthcare . Additionally, the Bio-RIDE scheme, approved in 2024 with a budget of 9,197 crore, focuses on research and development, entrepreneurship, and biomanufacturing to advance biotechnology and biomanufacturing in India .
Gene Silencing Market- Segmentation Analysis:
The global Gene Silencing Market is divided into four categories: Product & Service, Application, End Use and Region.
The gene silencing market is segmented into products and services, with the products segment dominating the market. This segment includes essential tools such as small interfering RNA (siRNA), short hairpin RNA (shRNA), and CRISPR/Cas9 systems, which play a critical role in gene knockdown, gene editing, and molecular biology research. The widespread adoption of these RNA-based technologies and CRISPR systems in genetic research, drug discovery, and personalized medicine drives the growth of this segment. Government initiatives, such as the U.S. National Institutes of Health (NIH) funding over $1 billion annually for gene editing research, and regulatory support for gene therapy development worldwide, significantly bolster innovation and market expansion in gene-targeted therapies.
The gene silencing market is also divided based on applications into drug discovery & development, therapeutics manufacturing, agricultural applications, and others, with drug discovery & development holding the dominant position. Gene silencing techniques are indispensable for identifying gene targets, unraveling disease mechanisms, and validating novel drug candidates, particularly in oncology and personalized medicine. The rising demand for precise and effective therapeutic options fuels the expansion of this segment. Government support, including policies like the European Union’s Horizon 2020 program, which allocates substantial funding towards advanced biotechnologies and drug development, further accelerates research and adoption of gene silencing in drug discovery, driving significant market growth globally.
Gene Silencing Market- Geographical Insights
The Gene Silencing Market is geographically distributed across North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa, with each region segmented further based on key contributing countries.
North America stands as a dominant force in the gene silencing market, led primarily by the United States and Canada. The U.S. is recognized globally for its leadership in biotechnology research, supported by significant investments in genetic research, drug discovery, and therapeutic development. The presence of major biotechnology companies, world-class research institutions, and robust government funding agencies such as the National Institutes of Health (NIH) substantially fuel market growth. Additionally, the region’s advanced healthcare infrastructure and the widespread adoption of personalized medicine and cutting-edge gene-editing technologies further drive demand for gene silencing products and services. Canada also plays a vital role with its expanding biotech industry and collaborative efforts in gene therapy, reinforcing North America’s leading position in the market.
Europe is another critical player in the gene silencing landscape, with countries like Germany, the United Kingdom, and France spearheading advancements. The region benefits from strong governmental support and substantial funding dedicated to biotechnology research, alongside a well-established pharmaceutical sector focused on genetic therapies. Europe’s growing focus on personalized medicine, combined with its sophisticated healthcare systems, creates a favorable environment for the development and adoption of gene silencing technologies. The presence of numerous leading research institutions, innovative biotechnology firms, and active clinical trials aimed at advancing gene therapy also contribute to robust market expansion. Moreover, the European Union’s collaborative regulatory framework facilitates seamless cooperation across member states, fostering innovation and accelerating the adoption of gene silencing solutions, thereby solidifying Europe’s position as a dominant region in the global market.
Gene Silencing Market- Competitive Landscape:
The gene silencing market is shaped by a dynamic mix of established industry leaders and innovative biotechnology startups. Prominent players such as Revvity, Inc., Danaher, Agilent Technologies, GenScript, Merck KGaA, Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, Bio-Techne, and New England Biolabs dominate the market by offering a broad range of advanced gene silencing products and services. These companies consistently invest in research and development to improve product efficacy, ensure regulatory compliance, and stay ahead of emerging trends. Meanwhile, new entrants are driving innovation by introducing cutting-edge technologies, including CRISPR-based tools, which enhance the precision and efficiency of gene silencing applications. This competitive environment fosters continuous technological advancement, expanding the market and accelerating progress in genetic research and therapeutic development.
Recent Developments:
- In February 2025, biotechnology firm Junevity secured $10 million in seed funding to advance its RESET platform, which leverages artificial intelligence and large-scale human data to identify transcription factors responsible for cellular damage. The platform employs siRNA therapeutics to target these factors and restore cellular health, with an initial focus on treating Type 2 diabetes, obesity, and frailty. Preclinical studies have demonstrated promising outcomes, including improved glucose regulation and up to 30% fat reduction in mice, with no observed adverse effects. Junevity’s approach also offers the advantage of infrequent dosing intervals—ranging from three to twelve months—potentially enhancing patient compliance. The company plans to progress multiple clinical programs aimed at addressing age-related diseases.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GENE SILENCING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Revvity, Inc.
- Danaher
- Agilent Technologies
- GenScript
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Illumina
- Bio-Rad Laboratories
- Bio-Techne
- New England Biolabs, Inc.
- Junevity
- Others
GLOBAL GENE SILENCING MARKET, BY PRODUCT & SERVICE - MARKET ANALYSIS, 2019 - 2032
- Products
- RNAi
- miRNA
- siRNA
- Others
- CRISPR-Cas9
- CRISPR Kits & Reagents
- CRISPR Libraries
- Others
- Antisense Oligonucleotides
- Others
- RNAi
- Services
GLOBAL GENE SILENCING MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032
- Drug Discovery & Development
- Neurology
- Oncology
- Infectious Diseases
- Metabolic Diseases
- Others
- Therapeutics Manufacturing
- Agricultural Applications
- Others
GLOBAL GENE SILENCING MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- CROs & CMOs
- Others
GLOBAL GENE SILENCING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Gene Silencing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Gene Silencing Market Snippet by Product & Service
2.1.2. Gene Silencing Market Snippet by Application
2.1.3. Gene Silencing Market Snippet by End Use
2.1.4. Gene Silencing Market Snippet by Country
2.1.5. Gene Silencing Market Snippet by Region
2.2. Competitive Insights
3. Gene Silencing Key Market Trends
3.1. Gene Silencing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Gene Silencing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Gene Silencing Market Opportunities
3.4. Gene Silencing Market Future Trends
4. Gene Silencing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Gene Silencing Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Gene Silencing Market Landscape
6.1. Gene Silencing Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Gene Silencing Market – By Product & Service
7.1. Overview
7.1.1. Segment Share Analysis, By Product & Service, 2023 & 2032 (%)
7.1.2. Products
7.1.2.1. RNAi
7.1.2.1.1. miRNA
7.1.2.1.2. siRNA
7.1.2.1.3. Others
7.1.2.2. CRISPR-Cas9
7.1.2.2.1. CRISPR Kits & Reagents
7.1.2.2.2. CRISPR Libraries
7.1.2.2.3. Others
7.1.2.3. Antisense Oligonucleotides
7.1.2.4. Others
7.1.3. Services
8. Gene Silencing Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
8.1.2. Drug Discovery & Development
8.1.2.1. Neurology
8.1.2.2. Oncology
8.1.2.3. Infectious Diseases
8.1.2.4. Metabolic Diseases
8.1.2.5. Others
8.1.3. Therapeutics Manufacturing
8.1.4. Agricultural Applications
8.1.5. Others
9. Gene Silencing Market – By End Use
9.1. Overview
9.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
9.1.2. Pharmaceutical & Biotechnology Companies
9.1.3. Academic & Research Institutes
9.1.4. CROs & CMOs
9.1.5. Others
10. Gene Silencing Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Gene Silencing Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Gene Silencing Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.8. France
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. France Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.3.8.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.9. Italy
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. Italy Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.10. Spain
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. United Kingdom Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.11. United Kingdom
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. United Kingdom Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.3.11.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.12. Russia
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Russia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.13. Netherlands
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Netherlands Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.14. Sweden
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Sweden Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.2. Poland Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Gene Silencing Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.9. South Korea
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. South Korea Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.10. Japan
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. Japan Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Gene Silencing Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Gene Silencing Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Gene Silencing Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Revvity, Inc.
11.2.2. Danaher
11.2.3. Agilent Technologies
11.2.4. GenScript
11.2.5. Merck KGaA
11.2.6. Thermo Fisher Scientific, Inc.
11.2.7. Illumina
11.2.8. Bio-Rad Laboratories
11.2.9. Bio-Techne
11.2.10. New England Biolabs, Inc.
11.2.11. Junevity
11.2.12. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
